Use of statins and associated factors in nonagenarians in the Community of Madrid, Spain.

Carlos LahozJuan Cárdenas-ValladolidMiguel Ángel Salinero-FortJosé María Mostaza

Published in: Aging clinical and experimental research (2021)

A significant percentage of nonagenarians-mainly less frail patients with more comorbidities-in the Community of Madrid receive statin treatment. No clear efficacy has been demonstrated in reducing cardiovascular events in an age group with such a short life expectancy.

Keyphrases

cardiovascular events
cardiovascular disease
coronary artery disease
mental health
healthcare
type diabetes
combination therapy
community dwelling
replacement therapy